Skip to main content
. 2016 Mar 31;11(3):e0151565. doi: 10.1371/journal.pone.0151565

Fig 1. Trial profile.

Fig 1

The figure shows the number of isolates analyzed at day 0 and on the Day of recurrent parasitaemia (recrudescence and new infections) by treatment group (AL and ASAQ) and the number of successful PCR-RFLP amplification.